Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Comment by newb4480on Feb 16, 2021 10:29am
75 Views
Post# 32572629

RE:RE:RE:fundimental research says .41 cents

RE:RE:RE:fundimental research says .41 centsI just signed up for the free account on FR. They have fair value listed at .41 and buy rating.

"With these revised estimates, our Discounted Cash Flow model returned a value per share estimate of $0.31 (previously $0.22). We are introducing a comparables valuation, based on an Enterprise Value to Revenue multiple, to capture the market sentiment, which returned a valuation of $0.52 per share. The average valuation of our two models is $0.41 per share."
<< Previous
Bullboard Posts
Next >>